Open Access Article
Mario Leypold
*a,
Lorenzo Poli
a,
Max Earl
a,
Okky D. Putra
b,
Karolina Kwapien
a,
Richard J. Lewis
a,
John J. Murphy
a,
Marta Passamonti
a,
Lena M. von Sydow
a,
Victor Spelling
c,
Ioannis Asproudis
b,
Malvika Sardana
c,
Claudia Gatti
d,
Hikaru Seki
a,
Thomas Lemaitre
a,
Radvile Juskaite
a,
Ranganath Gopalakrishnan
a,
Stuart J. Francis
a,
Cristina Gardelli
a,
Per-Ola Norrby
e and
Werngard Czechtizky
a
aMedicinal Chemistry, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D AstraZeneca, Pepparedsleden 1, 43183 Mölndal, Sweden. E-mail: mario.leypold@astrazeneca.com
bEarly Product Development and Manufacturing, Pharmaceutical Sciences, R&D AstraZeneca, Pepparedsleden 1, 43183 Mölndal, Sweden
cEarly Chemical Development, Pharmaceutical Sciences, R&D AstraZeneca, Pepparedsleden 1, 43183 Mölndal, Sweden
dEarly Chemical Development, Pharmaceutical Sciences, R&D AstraZeneca, Macclesfield SK10 2NA, UK
ePredictive Science, Digital and Automation, Pharmaceutical Sciences, R&D AstraZeneca, Pepparedsleden 1, 43183 Mölndal, Sweden
First published on 27th May 2026
Correction for ‘Regioselective synthesis of aza-saccharins via anionic [1,4] Fries-type rearrangement of aryl sulfonimidoyl fluorides’ by Mario Leypold et al., Chem. Sci., 2026, https://doi.org/10.1039/d6sc00432f.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2026 |